Rapt Therapeutics, Inc. (RAPT)
58.02
+0.04
(+0.07%)
USD |
NASDAQ |
Mar 02, 16:00
58.13
+0.11
(+0.19%)
After-Hours: 20:00
Rapt Therapeutics EPS Diluted (Quarterly) : -0.652 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Penumbra, Inc. | 1.202 |
| Amicus Therapeutics, Inc. | 0.0054 |
| Disc Medicine, Inc. | -1.618 |
| Amylyx Pharmaceuticals, Inc. | -0.3684 |
| Johnson & Johnson | 2.098 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.58M |
| Total Expenses (Quarterly) | 17.58M |
| Enterprise Value | 804.78M |
| Earnings Yield | -18.12% |
| Normalized Earnings Yield | -18.12 |